心导管电气烧灼术设备的全球市场

Global Cardiac Ablation Devices Market

出版日期: 2023年10月04日 | 出版商:

Frost & Sullivan | 英文 64 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

颠覆性技术推动创新

心律不整的增加和对微创治疗的需求不断增加正在推动心导管电气烧灼术（CA）市场的成长。此外，与 CA 程序相关的风险较小，这使得它们在世界各地受到青睐。由于 COVID-19 大流行对非紧急（选择性）医疗干预措施的限制，2020 年和 2021 年全球对 CA 手术的需求有所下降。从2022年开始，疫情法规将放宽，全球CA程序积压将导致CA设备市场成长激增。该市场包括CA系统、导管、发生器和其他产品领域。

CA 设备市场的参与企业已开始大力投资开发技术先进的解决方案，以快速、准确地治疗心律不整，同时改善患者的治疗效果。随着与新兴企业和技术供应商的合作不断增加，CA设备市场已经扩大，产品系列包括心律不整诊断中的人工智慧、基于感测器的可穿戴设备、提高准确性的机器人、先进的绘图系统、灵活的传感器晶片导管等。 .它以其先进的技术和解决方案获得了巨大的关注。

微创心律不整治疗的优惠报销和保险政策的可用性可能会进一步支持 CA 手术的市场。在CA手术技术中，射频消融仪占全球CA市场份额的65%以上，但冷冻消融设备因其微创方法而迅速普及。冷冻消融技术的进步和对智慧冷冻消融设备不断增长的需求正在导致这些创新技术的快速采用，从而在预测期内推动全球 CA 设备市场规模的成长。在亚太地区，基于球囊的冷冻消融和多电极冷冻消融是一些进步，导致更多地采用冷冻消融技术作为首选 CA 手术。

到 2022 年，美国基于导管的 CA 手术数量将超过心臟植入电子设备手术数量。过去年度，心臟 EP 手术在医疗保险中的比例显着增加，这主要是由基于导管的 CA 手术推动的。近年来，基于心导管的肺静脉隔离心房颤动治疗的 EP 手术率急剧增加。冷冻消融术普及，因为它可用于心臟直视手术和微创手术，并且在多个病例中已被证明是有效和安全的。这一增长是由 CA 程序的有利报销政策和亚太地区医疗旅游业的成长所推动的。用于将冷冻消融与药物疗法或射频消融相结合的混合方法的先进设备开发为患者提供了增强的、个体化的和更安全的治疗选择。

本研究报告分析了全球心导管电气烧灼术设备市场，并提出了整体市场前景，包括按最终用户、用途类型、设备类型和市场公司市场占有率比例。宏观经济要素、最新趋势、收益预测以及下一代 CA 技术和设备以及多个案例研究均已检验。研究期间为2021年至2027年，预测期间为2023年至2027年，以2022年为基准年。该研究重点关注颠覆性创新、未满足的新市场以及不断增加的心律不整患病，从而提供特定的市场成长机会。

心导管电气烧灼术设备市场
心导管电气烧灼术设备市场：依产品类型细分
心导管电气烧灼术设备市场：依程序细分
主要竞争
成长指标
成长促进因素
成长抑制因素
预测假设
收益预测
收益预测：按产品细分
收益预测：按地区
收益预测分析
预测分析
竞争环境
CA设备市场形势：依公司划分
CA设备市场形势：依最终用户分类

CA治疗-比较分析

什么是心导管电气烧灼术（CA）？
CA 与抗心律不整药物 (AAD)/心房颤动药物的比较
导管消融术和心臟节律器之间的比较？

CA治疗-护理连续分析

心房颤动筛检的主要建议
心导管电气烧灼术治疗 - 治疗
为什么（基于导管的）CA 需要这么长时间来管理？- 持续护理分析
心导管电气烧灼术市场－不断发展的生态系统
案例研究 1 -美国EP 程序趋势（2013-2020）

市场公司及解决方案列表

公司和产品清单 -心导管电气烧灼术解决方案
值得关注的心导管电气烧灼术系统/解决方案的顶级製造商

下一代心导管电气烧灼术技术和解决方案

心导管电气烧灼术新技术和技巧
下一代非加热心导管电气烧灼术系统 - Arga Medtech 的相干正弦波电穿孔 (CSE) 脉衝场消融 (PFA)
波士顿科学公司的 FARAPULSE(TM) PFA 系统
配备柔性电极头和接触力感测器的消融导管 - Abbott 的 TactiFlex(TM)
改良的温度监测导管 - Johnson & Johnson (JnJ) (Biosense Webster) 的 QDOT MICRO(TM) 导管
脉衝场消融 (PFA) - 下一代心导管电气烧灼术技术
市场领导为何投资 PFA 技术 - 美敦力 (Medtronic) 的 PulseSelect PFA 系统测试案例研究

成长机会宇宙

成长机会 1：下一代脉衝场消融技术
成长机会2：利用科技进步与人工智慧进行心律不整诊断
成长机会 3：电生理学机器人技术的未来
成长机会4：瞄准亚太地区

下一步

简介目录

Product Code: K94A-54

Disruptive Technologies Drive Innovation

Rising incidents of cardiac arrhythmia and the increasing demand for minimally invasive procedures boost the cardiac ablation (CA) market growth. In addition, fewer risks associated with the CA procedure make it a preference, worldwide. Global demand for CA procedures declined in 2020 and 2021 due to the COVID-19 pandemic restrictions on non-emergency (elective) medical interventions. With the lessening of pandemic restrictions from 2022, the worldwide backlog of CA procedures surged the CA device market growth. The market includes product segments of CA systems, catheters, generators, and others.

CA device market participants started investing heavily in technologically advanced solution development to treat cardiac arrhythmias quickly and precisely, with improved patient outcomes. With more collaborations with start-ups and technology providers, the CA device market is witnessing huge traction with advanced technologies and solutions in the product portfolio, such as AI in arrhythmia diagnosis, sensor-based wearables, robotics for enhanced precision, advanced mapping system, and flexible sensor-tip catheters.

The availability of favorable reimbursement and insurance policies for minimally invasive cardiac arrhythmia treatments will further support the market for CA procedures. In CA procedure technology, although RF ablators dominate the global CA market with more than 65% of the market share, cryoablation devices are rapidly gaining adoption due to their minimally invasive approach. Advancements in cryoablation technology and the growing demand for smart cryoablation devices are rapidly leading to the surge in the adoption of these innovative technologies and bolstering the global CA device market size in the forecast period. In APAC, balloon-based cryoablation and multi-electrode cryoablation are some advancements leading to increased adoption of cryoablation technology as a preferred CA procedure.

In 2022, the frequency of catheter-based CA procedures exceeded the number of cardiac implantable electronic device procedures in the US and is expected to surge during the forecast period. Rates of cardiac EP procedures in Medicare have increased considerably over the last decade, majorly driven by catheter-based CA procedures. The ratio of cardiac catheter-based EP procedures for pulmonary vein isolation for treating AFib has witnessed a rapid rise over the last few years. The prevalence of cryoablation for cardiac arrhythmia treatment, as it can be used in both open-heart and minimally invasive procedures, has proven effectiveness and safety in several cases. This growth is bolstered by favorable reimbursement policies for CA procedures and the growth of the medical tourism industry in APAC. Advanced device development for usage in a hybrid approach by combining cryoablation with drug therapy or RF ablation offers patients enhanced, personalized, and safer treatment options.

This study analyzes the global cardiac ablation device market, including the entire market landscape by end-users, application types, device types, and market share percentage by market players. It examines macroeconomic factors, the latest trends, revenue forecasts, and next-generation CA technologies and devices, along with a few case studies. The study period is from 2021 to 2027, and the forecast period is from 2023 to 2027, with 2022 as the base year. The study provides specific market growth opportunities focusing on disruptive innovations, new unaddressed markets, increasing prevalence of cardiac arrhythmia, and others. The study concludes with the top 4 growth opportunities in the CA device market.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Cardiac Ablation Devices Market
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Cardiac Ablation Devices Market
Cardiac Ablation Devices Market Segmentation by Product Types
Cardiac Ablation Devices Market Segmentation by Procedures
Key Competitors
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Product Segments
Revenue Forecast by Region
Revenue Forecast Analysis
Forecast Analysis
Competitive Environment
Landscape of CA Devices Market by Players
CA Devices Market Landscape by End Users

CA Procedure-Comparative Analysis

What is Cardiac Ablation (CA)?
CA vs. Antiarrhythmic Drugs (AAD)/Medication for Atrial Fibrillation
Catheter Ablation vs. Cardiac Pacing?

CA Procedure-Care Continuum Analysis

Key Recommendations for AFib Screening
Cardiac Ablation Therapy-The Procedure
Why (catheter-based) CA Is a Time-consuming Procedure-Care Continuum Analysis
The Cardiac Ablation Market-An Evolving Ecosystem
Case Study 1-Trends in the US EP Procedures (2013-2020)

Market Players and Solutions List

List of Players and Products-Cardiac Ablation Solutions
Top Cardiac Ablation System/solution Manufacturers to Watch

Cardiac Ablation Next-generation Technologies and Solutions

New Cardiac Ablation Technologies and Techniques
Next-gen Non-thermal Cardiac Ablation System-Arga Medtech's Coherent Sine-Burst Electroporation (CSE) Pulsed Field Ablation (PFA)
Boston Scientific's FARAPULSE™ PFA System
Ablation Catheter with Flexible Electrode Tip and Contact Force Sensing-Abbott's TactiFlex™
Catheter with Improved Temperature Monitoring-Johnson & Johnson's (JnJ) (Biosense Webster) QDOT MICRO™ Catheter
Pulsed Field Ablation (PFA)-Next-gen Cardiac Ablation Technique
Why Market Leaders are Investing in PFA Technology-Medtronic PulseSelect PFA System Trial Case Study

Growth Opportunity Universe

Growth Opportunity 1: Next-gen Technology of Pulsed Field Ablation
Growth Opportunity 2: Technological Advancements and AI Use in Cardiac Arrhythmia Diagnosis
Growth Opportunity 3: Future of Robotics in Electrophysiology
Growth Opportunity 4: Target APAC Region